Development
SOPHiA GENETICS SA
SOPH
$3.11
-$0.0368-1.17%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 31.14% | 30.13% | 23.34% | 19.68% | 17.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.14% | 30.13% | 23.34% | 19.68% | 17.58% |
| Cost of Revenue | 19.32% | 8.42% | 7.87% | 2.54% | 7.08% |
| Gross Profit | 37.31% | 42.85% | 32.34% | 30.11% | 23.92% |
| SG&A Expenses | -2.80% | -10.03% | -7.30% | 3.21% | 19.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -118.44% | -393.89% | 6.27% | -287.90% | -181.25% |
| Total Operating Expenses | 1.37% | -6.64% | -1.75% | 6.37% | 20.93% |
| Operating Income | 14.76% | 24.34% | 13.89% | 0.47% | -22.84% |
| Income Before Tax | 10.38% | 27.91% | 15.17% | 5.04% | -19.15% |
| Income Tax Expenses | 458.09% | 154.84% | -201.67% | -215.93% | -180.95% |
| Earnings from Continuing Operations | 9.68% | 27.37% | 15.53% | 5.59% | -18.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.68% | 27.37% | 15.53% | 5.59% | -18.70% |
| EBIT | 14.76% | 24.34% | 13.89% | 0.47% | -22.84% |
| EBITDA | 17.47% | 27.17% | 16.09% | 2.37% | -21.71% |
| EPS Basic | 10.55% | 27.91% | 17.17% | 13.00% | -2.81% |
| Normalized Basic EPS | 11.19% | 28.47% | 16.81% | 12.50% | -3.25% |
| EPS Diluted | 10.55% | 27.91% | 17.17% | 13.00% | -2.81% |
| Normalized Diluted EPS | 11.19% | 28.47% | 16.81% | 12.50% | -3.25% |
| Average Basic Shares Outstanding | 0.96% | 0.78% | 2.04% | 8.40% | 16.03% |
| Average Diluted Shares Outstanding | 0.96% | 0.78% | 2.04% | 8.40% | 16.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |